AGIO

NASDAQStock

Agios Pharmaceuticals, Inc.

$27.86+0.27 (+0.96%)

52-Week Range

$22.34

$45.49

Key Stats

Market Cap

1.6B

P/E Ratio

—

Dividend Yield

—

Beta

0.88

Volume

314.7K

Avg Volume

768.4K

Performance

+0.11%

+6.75%

-23.53%

YTD

+2.47%

-12.94%

+19.73%

-46.00%

Price Chart

ETF Exposure

AGIO is held by 110 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	5	$132	$60.6M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	16	$438	$80.3M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	27	$746	$80.4M	0.11%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	1,430	$39K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	1,430	$39K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	1,430	$39K	$1.0M	0.79%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	91	$3K	$820.6M	0.25%
VETS	Pacer Military Times Best Employers ETF	0.00%	1,430	$39K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	1,430	$39K	$3.7M	0.70%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	15	$583	$337.7M	0.32%

PreviousPage 3 of 3

About AGIO ETF Exposure

Agios Pharmaceuticals, Inc. (AGIO) is held by 110 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.6B, AGIO is a widely held institutional stock. The stock currently trades at $27.86. Investors can gain exposure to AGIO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold AGIO, sorted by portfolio weight.